AAL-993 entahydrate) RGFP966 was dosed to mice

RGFP966 was dosed to mice at 10 mg/Kg once per day by subcutaneous dosing

and analysed the expression of seven selected genes in the BDNF pathway by qPCR

has immunoenhancing activity by regulating production and gene expression of type 1 cytokines (IL-2

Smiles: CN(C)C(=O)CN1C=C(C=N1)C1C=CC(=CC=1)C1=CN=CC2C=CC=CC=21

Chemical Name: 6H

AAL-993 entahydrate) RGFP966 was dosed to miceIC50: 130, 23, and 18 nM for VEGFR1, 2, and 3, respectively AAL 993 is a VEGF receptor inhibitor. A key pro angiogenic cytokine released by tumor is vascular endothelial growth factor (VEGF). The angiogenic activity of the VEGF family of proteins is mediated by two high affinity receptors, VEGFR 1 and VEGFR 2 located on vascular endothelial cells. In vitro: AAL 993 was found to be a highly potent and selective inhibitor of the recombinant VEGFR 2 and